Three publications since last update:
- Clinical and economic impact of genome-wide noninvasive prenatal testing (NIPT) as a first-line screening method compared to targeted NIPT and first trimester combined testing: a modeling study | link
- Patient and population implications of multigene panels and pembrolizumab coverage in metastatic melanoma | link
- Costs and cost trajectory of genome sequencing and bioinformatics analysis for Indigenous children with suspected rare diseases | link
I’m excited to share some other publications I missed this week. Please let me know. I post these updates every Tuesday, but only if I see a related publication. If you don’t see updates on Tuesday, assume it was a quiet week for publications in the fields of health economics and genomics.
